Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveSclerosisAmyotrophic Lateral SclerosisEncephalomyelitis, Autoimmune, ExperimentalTuberous SclerosisDemyelinating DiseasesOptic NeuritisMyelin Basic ProteinMagnetic Resonance ImagingBrainScleroderma, SystemicMyelin SheathInterferon-betaOligoclonal BandsSpinal CordPeripheral NervesMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsDisability EvaluationOligodendrogliaMyelin-Associated GlycoproteinCentral Nervous SystemNeuromyelitis OpticaDisease ProgressionMyelin Proteolipid ProteinAtrophyImmunologic FactorsT-LymphocytesPeripheral Nervous System DiseasesCase-Control StudiesPeripheral Nervous SystemAxonsDisease Models, AnimalHLA-DR2 AntigenLeukocytes, MononuclearNerve Fibers, MyelinatedEncephalomyelitis, Acute DisseminatedPropylene GlycolsSeverity of Illness IndexCuprizoneDiffuse Cerebral Sclerosis of SchilderTime FactorsCells, CulturedNervous System DiseasesMice, Inbred C57BLPeripheral Vascular DiseasesDemyelinating Autoimmune Diseases, CNSRecurrenceTheilovirusLymphocyte ActivationAge of OnsetCerebrospinal FluidMicrogliaAutoimmune DiseasesHLA-DRB1 ChainsCerebrospinal Fluid ProteinsAutoimmunityOptic NerveLymphocytesFlow CytometryCytokinesImmunosuppressive AgentsNeurologic ExaminationImmunoglobulin GCD4-Positive T-LymphocytesHLA-DR AntigensBlood-Brain BarrierRemission, SpontaneousAutoantibodiesFatigueCardiovirus InfectionsFollow-Up StudiesNeuritisInflammationBiological MarkersMethylprednisoloneAstrocytesAutoantigensEvoked Potentials, VisualPeripheral Nerve InjuriesGenetic Predisposition to DiseaseTreatment OutcomeMice, TransgenicScleroderma, DiffuseStatistics, NonparametricPeripheral Arterial DiseaseReproducibility of ResultsInterferon-gammaNerve DegenerationB-LymphocytesMonocytesCentral Nervous System DiseasesAdjuvants, ImmunologicCohort StudiesGadoliniumImage EnhancementSensitivity and SpecificityPeptides